Cochrane Abstracts
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Iodine-131-meta-iodobenzylguanidine Therapy for Patients With Newly Diagnosed High-risk Neuroblastoma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438405/all/Lifestyle_interventions_for_the_treatment_of_women_with_gestational_diabetes_New. Accessed 19 April 2024.
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438405/all/Lifestyle_interventions_for_the_treatment_of_women_with_gestational_diabetes_New. Accessed April 19, 2024.
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438405/all/Lifestyle_interventions_for_the_treatment_of_women_with_gestational_diabetes_New
Iodine-131-meta-iodobenzylguanidine Therapy for Patients With Newly Diagnosed High-risk Neuroblastoma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438405/all/Lifestyle_interventions_for_the_treatment_of_women_with_gestational_diabetes_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma: Cochrane systematic review
ID - 438405
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438405/all/Lifestyle_interventions_for_the_treatment_of_women_with_gestational_diabetes_New
DB - Evidence Central
DP - Unbound Medicine
ER -
